Gephyrin Alterations Due to Protein Accumulation Stress are Reduced by the Lysosomal Modulator Z-Phe-Ala-Diazomethylketone

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Molecular Neuroscience

• Publication date

  2008-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s12031-007-9009-7PMID 18204977
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Microtubule-stabilizing agent prevents protein accumulation-induced loss of synaptic markers.

  2007influential reference
• Two pools of Triton X‐100‐insoluble GABAA receptors are present in the brain, one associated to lipid rafts and another one to the post‐synaptic GABAergic complex

  2007cited by this paper
• Potential Compensatory Responses Through Autophagic/Lysosomal Pathways in Neurodegenerative Diseases

  2006cited by this paper
• Cytoskeletal Transport in the Aging Brain: Focus on the Cholinergic System

  2006cited by this paper
• Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment.

  2006cited by this paper
• Presynaptic Terminals Independently Regulate Synaptic Clustering and Autophagy of GABAA Receptors in Caenorhabditis elegans

  2006cited by this paper
• Deciphering the structural framework of glycine receptor anchoring by gephyrin

  2006cited by this paper
• Cytoskeleton Regulation of Glycine Receptor Number at Synapses and Diffusion in the Plasma Membrane

  2006cited by this paper
• Dual Modulation of Endocannabinoid Transport and Fatty Acid Amide Hydrolase Protects against Excitotoxicity

  2005cited by this paper
• Stargazin modulates AMPA receptor gating and trafficking by distinct domains

  2005cited by this paper
• Gephyrin Regulates the Cell Surface Dynamics of Synaptic GABAA Receptors

  2005cited by this paper
• Differential regulation of GABAA receptor and gephyrin postsynaptic clustering in immature hippocampal neuronal cultures

  2005cited by this paper
• Age-Related Changes in the Inhibitory Response Properties of Dorsal Cochlear Nucleus Output Neurons: Role of Inhibitory Inputs

  2005cited by this paper
• Cellular Responses to Protein Accumulation Involve Autophagy and Lysosomal Enzyme Activation

  2005influential reference
• Ionotropic glutamate receptors and glutamate transporters are involved in necrotic neuronal cell death induced by oxygen-glucose deprivation of hippocampal slice cultures.

  2005cited by this paper
• Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease

  2005cited by this paper
• Blocking cannabinoid activation of FAK and ERK1/2 compromises synaptic integrity in hippocampus.

  2005cited by this paper
• Gephyrin Is Critical for Glycine Receptor Clustering But Not for the Formation of Functional GABAergic Synapses in Hippocampal Neurons

  2004cited by this paper
• Intracellular Association of Glycine Receptor with Gephyrin Increases Its Plasma Membrane Accumulation Rate

  2004cited by this paper
• Cytoskeletal changes in rat cortical neurons induced by long-term intraventricular infusion of leupeptin

  2004cited by this paper
• A focus on the synapse for neuroprotection in Alzheimer disease and other dementias

  2004cited by this paper
• Cathepsin L1, the Major Protease Involved in Liver Fluke (Fasciola hepatica) Virulence

  2004cited by this paper
• Biphasic NF-κB activation in the excitotoxic hippocampus

  2004cited by this paper
• Biphasic NF-kappaB activation in the excitotoxic hippocampus.

  2004cited by this paper
• Association of gephyrin with synaptic and extrasynaptic GABAA receptors varies during development in cultured hippocampal neurons.

  2003cited by this paper
• Lysosomal Activation Is a Compensatory Response Against Protein Accumulation and Associated Synaptopathogenesis—An Approach for Slowing Alzheimer Disease?

  2003influential reference
• Biochemical analysis of GABAA receptor subunits α1, α5, β1, β2 in the hippocampus of patients with Alzheimer's disease neuropathology

  2003cited by this paper
• Biochemical analysis of GABA(A) receptor subunits alpha 1, alpha 5, beta 1, beta 2 in the hippocampus of patients with Alzheimer's disease neuropathology.

  2003cited by this paper
• Distribution of gephyrin in the human brain: an immunohistochemical analysis.

  2003cited by this paper
• GABAergic and glutamatergic terminals differentially influence the organization of GABAergic synapses in rat cerebellar granule cells in vitro.

  2002cited by this paper
• Intracellular Deposition, Microtubule Destabilization, and Transport Failure: An “Early” Pathogenic Cascade Leading to Synaptic Decline

  2002influential reference
• Gephyrin Interacts with Dynein Light Chains 1 and 2, Components of Motor Protein Complexes

  2002cited by this paper
• The neuropathogenic contributions of lysosomal dysfunction

  2002cited by this paper
• Molecular heterogeneity of central synapses: afferent and target regulation

  2001cited by this paper
• The glycinergic inhibitory synapse

  2001cited by this paper
• Age‐related decline of presumptive inhibitory synapses in the sensorimotor cortex as revealed by the physical disector

  2001cited by this paper
• The expression of vesicular glutamate transporters defines two classes of excitatory synapse.

  2001cited by this paper
• Clustering of inhibitory neurotransmitter receptors at developing postsynaptic sites: the membrane activation model.

  2000cited by this paper
• Effects of Chronic Ethanol Treatment on γ-Aminobutyric AcidA and Glycine Receptors in Mouse Glycinergic Spinal Neurons

  2000cited by this paper
• A “Protease Activation Cascade” in the Pathogenesis of Alzheimer's Disease

  2000cited by this paper
• Diversity and phylogeny of gephyrin: tissue-specific splice variants, gene structure, and sequence similarities to molybdenum cofactor-synthesizing and cytoskeleton-associated proteins.

  2000cited by this paper
• Functional heterogeneity of gephyrins.

  2000cited by this paper
• Loss of Postsynaptic GABAA Receptor Clustering in Gephyrin-Deficient Mice

  1999cited by this paper
• Interaction of RAFT1 with gephyrin required for rapamycin-sensitive signaling.

  1999cited by this paper
• Postsynaptic clustering of major GABAA receptor subtypes requires the gamma 2 subunit and gephyrin.

  1998cited by this paper
• Molecular mechanisms that underlie structural and functional changes at the postsynaptic membrane during synaptic plasticity.

  1998influential reference
• Inhibitory neuronal activity can compensate for adverse effects of β-amyloid in hippocampal neurons

  1998cited by this paper
• Postsynaptic clustering of major GABAA receptor subtypes requires the γ2 subunit and gephyrin

  1998cited by this paper
• Inhibitory neuronal activity can compensate for adverse effects of beta-amyloid in hippocampal neurons.

  1998cited by this paper
• Chloroquine myopathy suggests that tau is degraded in lysosomes: implication for the formation of paired helical filaments in Alzheimer's disease.

  1998cited by this paper
• Chloroquine administration in mice increases beta-amyloid immunoreactivity and attenuates kainate-induced blood-brain barrier dysfunction.

  1997cited by this paper
• Chloroquine administration in mice increases β-amyloid immunoreactivity and attenuates kainate-induced blood–brain barrier dysfunction

  1997cited by this paper
• Variants of the receptor/channel clustering molecule gephyrin in brain: Distinct distribution patterns, developmental profiles, and proteolytic cleavage by calpain

  1997influential reference
• Immunohistochemical study of GABA(A) receptor beta2/3 subunits in the hippocampal formation of aged brains with Alzheimer-related neuropathologic changes.

  1997cited by this paper
• Distinct distributions of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor subunits and a related 53,000 Mr antigen (GR53) in brain tissue

  1996cited by this paper
• Clustering of Gephyrin at GABAergic but Not Glutamatergic Synapses in Cultured Rat Hippocampal Neurons

  1996cited by this paper
• Long‐term hippocampal slices: A model system for investigating synaptic mechanisms and pathologic processes

  1995cited by this paper
• Colocalization of gephyrin and GABAA‐receptor subunits in the rat retina

  1995cited by this paper
• Mechanisms of synaptic dysfunction in Alzheimer's disease.

  1995cited by this paper
• Stable maintenance of glutamate receptors and other synaptic components in long‐term hippocampal slices

  1995cited by this paper
• Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease.

  1995cited by this paper
• Induction of beta-amyloid-containing polypeptides in hippocampus: evidence for a concomitant loss of synaptic proteins and interactions with an excitotoxin.

  1994influential reference
• Delayed Protection by MK‐801 and Tetrodotoxin in a Rat Organotypic Hippocampal Culture Model of Ischemia

  1994cited by this paper
• Widespread expression of gephyrin, a putative glycine receptor-tubulin linker protein, in rat brain.

  1993cited by this paper
• Gephyrin antisense oligonucleotides prevent glycine receptor clustering in spinal neurons

  1993cited by this paper
• Primary structure and alternative splice variants of gephyrin, a putative glycine receptor-tubulin linker protein.

  1992cited by this paper
• Chloroquine inhibits intracellular degradation but not secretion of Alzheimer beta/A4 amyloid precursor protein.

  1992cited by this paper
• Regional synaptic pathology in Alzheimer's disease.

  1992cited by this paper
• Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

  1991cited by this paper
• Effects of inhibitors of protein degradation on the rate of protein synthesis in Chinese Hamster Ovary cells

  1984cited by this paper

• Identifying a novel Mecp2-mediated epigenetic mechanism controlling Lonp1 in the hippocampus and its disruption by aging

  2025cites this paper
• The Role of Lysosomes in a Broad Disease-Modifying Approach Evaluated across Transgenic Mouse Models of Alzheimer’s Disease and Parkinson’s Disease and Models of Mild Cognitive Impairment

  2019cites this paper
• Potential Alzheimer's Disease Therapeutics Among Weak Cysteine Protease Inhibitors Exhibit Mechanistic Differences Regarding Extent of Cathepsin B Up-Regulation and Ability to Block Calpain.

  2017cites this paper
• Aβ42-mediated proteasome inhibition and associated tau pathology in hippocampus are governed by a lysosomal response involving cathepsin B: Evidence for protective crosstalk between protein clearance pathways

  2017cites this paper
• A Single Pathway Targets Several Health Challenges of the Elderly

  2014cites this paper
• Equipotent Inhibition of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase – Dual Targets of the Endocannabinoid System to Protect against Seizure Pathology

  2012cites this paper
• Nonpeptidic lysosomal modulators derived from z-phe-ala-diazomethylketone for treating protein accumulation diseases.

  2012cites this paper
• Positive Lysosomal Modulation As a Unique Strategy to Treat Age-Related Protein Accumulation Diseases

  2012cites this paper
• A New Generation Fatty Acid Amide Hydrolase Inhibitor Protects Against Kainate-Induced Excitotoxicity

  2011cites this paper
• Protective Effects of Positive Lysosomal Modulation in Alzheimer's Disease Transgenic Mouse Models

  2011cites this paper
• Lysosomal modulatory drugs for a broad strategy against protein accumulation disorders.

  2009cites this paper